Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
Nov 11, 2024 • 4min
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading
Dr. Halley Alexander discusses the Neurology Today article, "Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading" by Gina Shaw, available in the November 7th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2024&issue=11070&article=00001&type=Fulltext
Nov 8, 2024 • 2min
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Nov 7, 2024 • 2min
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192
Nov 6, 2024 • 2min
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease. Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457
Nov 5, 2024 • 3min
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Dr. Rae Bacharach discusses the Neurology Today article, "Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease," by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/pages/default.aspx https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964
Nov 4, 2024 • 5min
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3
In the final part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss what you need to know about analyzing network meta-analysis. Show reference: https://www.bmj.com/content/386/bmj-2024-080107
Nov 1, 2024 • 2min
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
Discover the revolutionary use of eculizumab, a complement inhibitor, in treating Neuromyelitis Optica Spectrum Disorders. The conversation highlights its unique mechanism and discusses essential precautions, including vaccination and antibiotics, to ensure patient safety. Tune in to explore the potential side effects and the future of this innovative therapy.
Oct 31, 2024 • 5min
Interventions for the Acute Management of Migraine Episodes in Adults - Part 2
In part two of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani discuss clinical pearls on how to select an acute treatment plan for migraine. Show reference: https://www.bmj.com/content/386/bmj-2024-080107
Oct 30, 2024 • 5min
Interventions for the Acute Management of Migraine Episodes in Adults - Part 1
In the first part of this three-part series, Drs. Tesha Monteith, Messoud Ashina, and Andrea Cipriani explain the significance of this study and how its findings can be applied in clinical practice. Show reference: https://www.bmj.com/content/386/bmj-2024-080107
Oct 29, 2024 • 2min
Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves
Dr. Jodie Roberts and Dr. Amra Sakusic discusses the relationship between reversal therapy and ischemic stroke, between duration off anticoagulation and risk of ischemic strokes or systemic embolism. Learn more about the Neurology Practice Current section and fill out the survey now. Show reference: https://survey.alchemer.com/s3/7969148/Practice-Current-When-do-you-start-anticoagulation-therapy-for-patients-with-both-ICH-and-AF https://www.neurology.org/doi/10.1212/WNL.0000000000209664
